Mechanical circulatory support device selection for bridging to cardiac transplantation: a clinical guide

References

• Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA guideline for the management of heart failure. Circulation. 2013;128(16):e240–327. DOI:10.1161/CIR.0b013e31829e8776
   PubMed Web of Science ®Google Scholar
• OPTN. Adult heart allocation changes 2018. (2018).
   Google Scholar
• Committee OTT One-year monitoring of heart allocation proposal to modify the heart allocation system. (Ed.^(Eds)
   Google Scholar
• Cogswell R, John R, Estep JD, et al. An early investigation of outcomes with the new 2018 donor heart allocation system in the United States. J Heart Lung Transplant. 2020;39(1):1–4. DOI:10.1016/j.healun.2019.11.002
   PubMed Web of Science ®Google Scholar
• Goff RR, Uccellini K, Lindblad K, et al. A change of heart: preliminary results of the US 2018 adult heart allocation revision. Am J Transplant. 2020;20(10):2781–2790. DOI:10.1111/ajt.16010
   PubMed Web of Science ®Google Scholar
• OPTN. OPTN policy 6: allocation of hearts and heart-lungs (Ed.^(eds) (2023)
   Google Scholar
• Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341(9):625–634. DOI:10.1056/NEJM199908263410901
   PubMed Web of Science ®Google Scholar
• Thiele H, Zeymer U, Neumann F-J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287–1296. DOI:10.1056/NEJMoa1208410
   PubMed Web of Science ®Google Scholar
• Naidu SS, Baran DA, Jentzer JC, et al. SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies: this statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol. 2022;79(9):933–946. DOI:10.1016/j.jacc.2022.01.018
   PubMedGoogle Scholar
• Naidu SS, Baran DA, Jentzer JC, et al. SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies: this statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. Catheter Cardiovasc Interv. 2022;1(1).
   Google Scholar
• Thayer KL, Zweck E, Ayouty M, et al. Invasive hemodynamic assessment and classification of in-hospital mortality risk among patients with cardiogenic shock. Circ Heart Fail. 2020;13(9):e007099. DOI:10.1161/CIRCHEARTFAILURE.120.007099
   PubMed Web of Science ®Google Scholar
• Baran DA, Long A, Badiye AP, et al. Prospective validation of the SCAI shock classification: single center analysis. Catheterization Cardiovasc Interventions. 2020;96(7):1339–1347.
   PubMed Web of Science ®Google Scholar
• Hanson ID, Tagami T, Mando R, et al. SCAI shock classification in acute myocardial infarction: insights from the National Cardiogenic Shock Initiative. Catheterization Cardiovasc Interventions. 2020;96(6):1137–1142. DOI:10.1002/ccd.29139
   PubMed Web of Science ®Google Scholar
• Jentzer JC, van Diepen S, Barsness GW, et al. Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit population. Am Heart J. 2019;215:12–19.
   PubMed Web of Science ®Google Scholar
• Topkara VK, Sayer GT, Clerkin KJ, et al. Recovery with temporary mechanical circulatory support while waitlisted for heart transplantation. J Am Coll Cardiol. 2022;79(9):900–913. DOI:10.1016/j.jacc.2021.12.022
   PubMed Web of Science ®Google Scholar
• Esposito M, Bader Y, Pedicini R, et al. The role of acute circulatory support in ST-segment elevation myocardial infarction complicated by cardiogenic shock. Indian Heart J. 2017;69(5):668–674.
   PubMedGoogle Scholar
• Udesen NJ, Moller JE, Lindholm MG, et al. Rationale and design of DanGer shock: danish-German cardiogenic shock trial. Am Heart J. 2019;214:60–68.
   PubMed Web of Science ®Google Scholar
• Thiele H, Freund A, Gimenez MR, et al. Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trial. Am Heart J. 2021;234:1–11.
   PubMed Web of Science ®Google Scholar
• Clerkin KJ, Salako O, Fried JA, et al. Impact of temporary percutaneous mechanical circulatory support before transplantation in the 2018 heart allocation system. JACC Heart Fail. 2022;10(1):12–23. DOI:10.1016/j.jchf.2021.08.003
   PubMed Web of Science ®Google Scholar
• Nishida H, Koda Y, Kalantari S, et al. Outcomes of ambulatory axillary intraaortic balloon pump as a bridge to heart transplantation. Ann Thorac Surg. 2021;111(4):1264–1270. DOI:10.1016/j.athoracsur.2020.06.077
   PubMed Web of Science ®Google Scholar
• Tanaka A, Tuladhar SM, Onsager D, et al. The subclavian intraaortic balloon pump: a compelling bridge device for advanced heart failure. Ann Thorac Surg. 2015;100(6):2151–2158. DOI:10.1016/j.athoracsur.2015.05.087
   PubMed Web of Science ®Google Scholar
• Thiele H, Zeymer U, Thelemann N, et al. Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction. Circulation. 2019;139(3):395–403. DOI:10.1161/CIRCULATIONAHA.118.038201
   PubMed Web of Science ®Google Scholar
• Fried JA, Nair A, Takeda K, et al. Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock. J Heart Lung Transplant. 2018;37(11):1313–1321. DOI:10.1016/j.healun.2018.03.011
   PubMed Web of Science ®Google Scholar
• Huang AL, Fried JA, Malick W, et al. Predictors Of hemodynamic response to intra-aortic balloon pump therapy in patients with acute decompensated heart failure and cardiogenic shock. J Invasive Cardiol. 2021;33(4):E275–280.
   PubMed Web of Science ®Google Scholar
• Ramzy D, Soltesz E, Anderson M. New surgical circulatory support system outcomes. Asaio J. 2020;66(7):746–752.
   PubMed Web of Science ®Google Scholar
• Hall SA, Uriel N, Carey SA, et al. Use of a percutaneous temporary circulatory support device as a bridge to decision during acute decompensation of advanced heart failure. J Heart Lung Transplant. 2018;37(1):100–106. DOI:10.1016/j.healun.2017.09.020
   PubMed Web of Science ®Google Scholar
• Lima B, Kale P, Gonzalez-Stawinski GV, et al. Effectiveness and Safety Of The Impella 5.0 As A Bridge To Cardiac Transplantation Or Durable Left Ventricular Assist Device. Am J Cardiol. 2016;117(10):1622–1628.
   PubMed Web of Science ®Google Scholar
• Chung JS, Emerson D, Ramzy D, et al. A new paradigm in mechanical circulatory support: 100-patient experience. Ann Thorac Surg. 2020;109(5):1370–1377. DOI:10.1016/j.athoracsur.2019.08.041
   PubMed Web of Science ®Google Scholar
• Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52(19):1584–1588. DOI:10.1016/j.jacc.2008.05.065
   PubMed Web of Science ®Google Scholar
• Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017;69(3):278–287. DOI:10.1016/j.jacc.2016.10.022
   PubMed Web of Science ®Google Scholar
• Akanni O, Garan AR, Takayama H, et al. (89) - novel minimally invasive surgical approach for refractory cardiogenic shock: a hemodynamic comparison with current percutaneous strategies. J Heart Lung Transplant. 2018;37(4, Supplement):S44–45. DOI:10.1016/j.healun.2018.01.091
   Web of Science ®Google Scholar
• Truby LK, Takeda K, Mauro C, et al. Incidence and implications of left ventricular distention during venoarterial extracorporeal membrane oxygenation support. Asaio J. 2017;63(3):257–265. DOI:10.1097/MAT.0000000000000553
   PubMed Web of Science ®Google Scholar
• Ostadal P, Rokyta R, Karasek J, et al. Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial. Circulation. 2023;147(6):454–464. DOI:10.1161/CIRCULATIONAHA.122.062949
   PubMed Web of Science ®Google Scholar
• Rajsic S, Treml B, Jadzic D, et al. Extracorporeal membrane oxygenation for cardiogenic shock: a meta-analysis of mortality and complications. Ann Intensive Care. 2022;12(1):93. DOI:10.1186/s13613-022-01067-9
   PubMed Web of Science ®Google Scholar
• Yin MY, Wever-Pinzon O, Mehra MR, et al. Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. J Heart Lung Transplant. 2019;38(8):858–869. DOI:10.1016/j.healun.2019.04.003
   PubMed Web of Science ®Google Scholar
• Zalawadiya S, Fudim M, Bhat G, et al. Extracorporeal membrane oxygenation support and post-heart transplant outcomes among United States adults. J Heart Lung Transplant. 2017;36(1):77–81.
   PubMed Web of Science ®Google Scholar
• Mehra MR, Goldstein DJ, Cleveland JC, et al. Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial. JAMA. 2022;328(12):1233–1242. DOI:10.1001/jama.2022.16197
   PubMed Web of Science ®Google Scholar
• Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435–1443. DOI:10.1056/NEJMoa012175
   PubMed Web of Science ®Google Scholar
• Potapov EV, Nersesian G, Lewin D, et al. Propensity score-based analysis of long-term follow-up in patients supported with durable centrifugal left ventricular assist devices: the EUROMACS analysis. Eur J Cardiothorac Surg. 2021;60(3):579–587. DOI:10.1093/ejcts/ezab144
   PubMed Web of Science ®Google Scholar
• Mehra MR, Uriel N, Naka Y, et al. A fully magnetically levitated left ventricular assist device — final report. N Engl J Med. 2019;380(17):1618–1627. DOI:10.1056/NEJMoa1900486
   PubMed Web of Science ®Google Scholar
• Mullan CW, Chouairi F, Sen S, et al. Changes in use of left ventricular assist devices as bridge to transplantation with new heart allocation policy. JACC Heart Fail. 2021;9(6):420–429. DOI:10.1016/j.jchf.2021.01.010
   PubMed Web of Science ®Google Scholar
• Uriel MH, Clerkin KJ, Takeda K, et al. Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: an individualized approach. J Heart Lung Transplant. 2022;42(1):124–133. DOI:10.1016/j.healun.2022.08.022
   PubMed Web of Science ®Google Scholar
• Cheung A, Leprince P, Freed D. First clinical evaluation of a novel percutaneous right ventricular assist device: the impella rp. J Am Coll Cardiol. 2012;59(13_Supplement):E872.
   Web of Science ®Google Scholar
• Anderson MB, Goldstein J, Milano C, et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant. 2015;34(12):1549–1560. DOI:10.1016/j.healun.2015.08.018
   PubMed Web of Science ®Google Scholar
• Topkara VK, Elias P, Jain R, et al. Machine learning-based prediction of myocardial recovery in patients with left ventricular assist device support. Circ Heart Fail. 2022;15(1):e008711.
   PubMed Web of Science ®Google Scholar
• Jain R, Habal MV, Clerkin KJ, et al. De Novo human leukocyte antigen allosensitization in heartmate 3 versus heartmate ii left ventricular assist device recipients. Asaio J. 2021;Publish Ahead of Print. doi:10.1097/MAT.0000000000001451.
   Google Scholar